SHAWN T CAROLAN, a director at $CHYM, sold 1,965 shares of the company on 09-10-2026 for an estimated $65,248. We received data on the trade from a recent SEC filing. This was a sale of approximately 52.2% of their shares of this class of stock. Following this trade, they now own 1,800 shares of this class of $CHYM stock.
$CHYM Insider Trading Activity
$CHYM insiders have traded $CHYM stock on the open market 269 times in the past 6 months. Of those trades, 0 have been purchases and 269 have been sales.
Here’s a breakdown of recent trading of $CHYM stock by insiders over the last 6 months:
- GLOBAL ADVISORS LTD DST has made 0 purchases and 238 sales selling 25,652,840 shares for an estimated $838,043,037.
- CHRISTOPHER R BRITT (Chief Executive Officer) has made 0 purchases and 10 sales selling 850,000 shares for an estimated $26,271,578.
- SHAWN T CAROLAN has made 0 purchases and 6 sales selling 579,313 shares for an estimated $19,194,539.
- RYAN A KING (Co-Founder) has made 0 purchases and 4 sales selling 417,421 shares for an estimated $12,841,242.
- JAMES FEUILLE has made 0 purchases and 3 sales selling 351,890 shares for an estimated $11,611,184.
- MATTHEW S NEWCOMB (Chief Financial Officer) has made 0 purchases and 2 sales selling 65,000 shares for an estimated $1,961,000.
- AMINE ASMEROM (Chief Accounting Officer) has made 0 purchases and 4 sales selling 39,505 shares for an estimated $1,192,529.
- ADAM B FRANKEL (General Counsel) has made 0 purchases and 2 sales selling 6,000 shares for an estimated $106,500.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CHYM Hedge Fund Activity
We have seen 178 institutional investors add shares of $CHYM stock to their portfolio, and 122 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ICONIQ CAPITAL, LLC removed 11,064,137 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $226,593,525
- COATUE MANAGEMENT LLC removed 10,071,992 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $206,274,396
- BLACKROCK, INC. added 9,819,060 shares (+688.9%) to their portfolio in Q2 2026, for an estimated $201,094,348
- TIGER GLOBAL MANAGEMENT LLC removed 8,908,454 shares (-62.8%) from their portfolio in Q2 2026, for an estimated $182,445,137
- POINT72 ASSET MANAGEMENT, L.P. removed 4,586,956 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $85,913,685
- SCGE MANAGEMENT, L.P. removed 4,181,827 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $85,643,816
- CITADEL ADVISORS LLC removed 3,709,869 shares (-55.9%) from their portfolio in Q1 2026, for an estimated $69,485,846
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CHYM Revenue
$CHYM had revenues of $669.8M in Q2 2026. This is an increase of 23.23% from the same period in the prior year.
You can track CHYM financials on Quiver Quantitative's CHYM stock page.
You can access data on CHYM stock through the Quiver Quantitative API.
$CHYM Price Targets
Multiple analysts have issued price targets for $CHYM recently. We have seen 5 analysts offer price targets for $CHYM in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Nik Cremo from Barclays set a target price of $26.0 on 07/08/2026
- Joseph Vafi from Canaccord Genuity set a target price of $40.0 on 05/11/2026
- Cassie Chan from Wells Fargo set a target price of $28.0 on 05/07/2026
- Andrew Bauch from BMO Capital set a target price of $30.0 on 04/22/2026
- Giuliano Bologna from Compass Point set a target price of $27.0 on 04/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
